Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Mr. Olivier Loeillot es el President de Repligen Corp, se unió a la empresa desde 2023.
¿Qué tal es el rendimiento del precio de la acción RGEN?
El precio actual de RGEN es de $138.61, ha aumentado un 1.18% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Repligen Corp?
Repligen Corp pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Repligen Corp?
La capitalización bursátil actual de Repligen Corp es $7.8B
¿Es Repligen Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 22 analistas han realizado calificaciones de análisis para Repligen Corp, incluyendo 7 fuerte compra, 16 compra, 5 mantener, 0 venta, y 7 fuerte venta